VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
+12.31%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$127M
AUM Growth
+$127M
(-7.6%)
Cap. Flow
-$28.6M
Cap. Flow
% of AUM
-22.52%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$28.6M |
Sector Composition
| 1 | Healthcare | 60.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
1
DELISTED
Audentes Therapeutics, Inc
BOLD
| $34.6M | 27.2% | 1,806,832 | – | – |
|
|
AKAO
2
DELISTED
Achaogen, Inc.
AKAO
| $27.9M | 21.91% | 1,281,152 | – | – |
|
|
IMDZ
3
DELISTED
Immune Design Corp.
IMDZ
| $21.3M | 16.76% | 2,208,210 | – | – |
|
4
Ocular Therapeutix
OCUL
$2.12B
| $20.5M | 16.15% | 2,215,384 | – | – |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $9.54M | 7.51% | 101,855 -305,561 | -75% | -$28.6M |
|
|
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
| $6.04M | 4.75% | 1,048,601 | – | – |
|
7
Vivani Medical
VANI
$68.1M
| $5.62M | 4.42% | 4,492,975 | – | – |
|
|
OPGN
8
DELISTED
OpGen, Inc
OPGN
| $1.65M | 1.3% | 2,554,211 | – | – |
|